← back to search

Tabitha A. Harrison

University of Washington · US
Area of research
Genetics · Oncology
Research interest
Research interests include Colorectal Cancer Screening and Detection, Genetic factors in colorectal cancer, Genetic Associations and Epidemiology, and Nutrition, Genetics, and Disease.
h-index
44
citations
10,991
works
523
NIH funding
primary concept
Medicine
email

Recent publications

Assessing genotype−phenotype correlations in colorectal cancer with deep learning: a multicentre cohort study
The Lancet Digital Health 2025cited by 6position: middledoi
Physical activity and molecular subtypes of colorectal cancer: a pooled observational analysis and Mendelian randomization study
JNCI Cancer Spectrum 2025cited by 1position: middledoi
Waist Circumference, a Body Shape Index, and Molecular Subtypes of Colorectal Cancer: A Pooled Analysis of Four Cohort Studies
Cancer Epidemiology Biomarkers & Prevention 2025cited by 1position: middledoi
Genetic risk factors modulate the association between physical activity and colorectal cancer
Research Square 2025cited by 1position: middledoi
Genome-wide association studies and Mendelian randomization analyses provide insights into the causes of early-onset colorectal cancer
Annals of Oncology 2024cited by 67position: middledoi
Fine-mapping analysis including over 254,000 East Asian and European descendants identifies 136 putative colorectal cancer susceptibility genes
Nature Communications 2024cited by 18position: middledoi
Genome-wide interaction study of dietary intake of fibre, fruits, and vegetables with risk of colorectal cancer
EBioMedicine 2024cited by 12position: middledoi
Genetic risk impacts the association of menopausal hormone therapy with colorectal cancer risk
British Journal of Cancer 2024cited by 10position: middledoi
Body size and risk of colorectal cancer molecular defined subtypes and pathways: Mendelian randomization analyses
EBioMedicine 2024cited by 9position: middledoi
Two genome-wide interaction loci modify the association of nonsteroidal anti-inflammatory drugs with colorectal cancer
Science Advances 2024cited by 6position: middledoi
Epidemiologic Factors in Relation to Colorectal Cancer Risk and Survival by Genotoxic Colibactin Mutational Signature
Cancer Epidemiology Biomarkers & Prevention 2024cited by 3position: middledoi
Folate intake and colorectal cancer risk according to genetic subtypes defined by targeted tumor sequencing
American Journal of Clinical Nutrition 2024cited by 3position: middledoi
The association between genetically elevated polyunsaturated fatty acids and risk of cancer
EBioMedicine 2023cited by 52position: middledoi
Genome-wide analyses characterize shared heritability among cancers and identify novel cancer susceptibility regions
JNCI Journal of the National Cancer Institute 2023cited by 30position: middledoi
Prognostic role of detailed colorectal location and tumor molecular features: analyses of 13,101 colorectal cancer patients including 2994 early-onset cases
Journal of Gastroenterology 2023cited by 28position: middledoi
Combining Asian and European genome-wide association studies of colorectal cancer improves risk prediction across racial and ethnic populations
Nature Communications 2023cited by 27position: middledoi
Genotoxic colibactin mutational signature in colorectal cancer is associated with clinicopathological features, specific genomic alterations and better survival
medRxiv 2023cited by 22position: middledoi
Genome-Wide Gene–Environment Interaction Analyses to Understand the Relationship between Red Meat and Processed Meat Intake and Colorectal Cancer Risk
Cancer Epidemiology Biomarkers & Prevention 2023cited by 15position: middledoi
A Genetic Locus within the FMN1/GREM1 Gene Region Interacts with Body Mass Index in Colorectal Cancer Risk
Cancer Research 2023cited by 14position: middledoi
Probing the diabetes and colorectal cancer relationship using gene – environment interaction analyses
British Journal of Cancer 2023cited by 14position: middledoi
Genome-wide interaction analysis of folate for colorectal cancer risk
American Journal of Clinical Nutrition 2023cited by 11position: middledoi
Elucidating the Risk of Colorectal Cancer for Variants in Hereditary Colorectal Cancer Genes
Gastroenterology 2023cited by 6position: middledoi
Validation of a Genetic-Enhanced Risk Prediction Model for Colorectal Cancer in a Large Community-Based Cohort
Cancer Epidemiology Biomarkers & Prevention 2023cited by 6position: middledoi
Author Correction: Deciphering colorectal cancer genetics through multi-omic analysis of 100,204 cases and 154,587 controls of European and east Asian ancestries
Nature Genetics 2023cited by 4position: middledoi
Genome‐wide study of genetic polymorphisms predictive for outcome from first‐line oxaliplatin‐based chemotherapy in colorectal cancer patients
International Journal of Cancer 2023cited by 4position: middledoi
Using DEPendency of Association on the Number of Top Hits (DEPTH) as a Complementary Tool to Identify Novel Colorectal Cancer Susceptibility Loci
Cancer Epidemiology Biomarkers & Prevention 2023cited by 2position: middledoi
Combining Asian-European Genome-Wide Association Studies of Colorectal Cancer Improves Risk Prediction Across Race and Ethnicity
medRxiv 2023cited by 1position: middledoi
Deciphering colorectal cancer genetics through multi-omic analysis of 100,204 cases and 154,587 controls of European and east Asian ancestries
Nature Genetics 2022cited by 234position: middledoi
Molecular Characteristics of Early-Onset Colorectal Cancer According to Detailed Anatomical Locations: Comparison With Later-Onset Cases
The American Journal of Gastroenterology 2022cited by 60position: middledoi
Risk Stratification for Early-Onset Colorectal Cancer Using a Combination of Genetic and Environmental Risk Scores: An International Multi-Center Study
JNCI Journal of the National Cancer Institute 2022cited by 51position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Ulrike Peters · Fred Hutch Cancer Center18 papers (2014–2025)Andrew T. Chan · Monash Institute of Medical Research16 papers (2014–2023)Polly A. Newcomb · University of Washington15 papers (2014–2023)Jenny Chang‐Claude · Centre hospitalier universitaire de Québec14 papers (2014–2023)Michael Hoffmeister · Festo (Germany)13 papers (2014–2023)Hermann Brenner · Stanford University13 papers (2014–2023)Martha L. Slattery · Massachusetts General Hospital12 papers (2014–2021)Robert E. Schoen · University of Pittsburgh10 papers (2014–2022)Mark A. Jenkins · Georgia Southern University9 papers (2018–2023)Peter T. Campbell · Montefiore Einstein Comprehensive Cancer Center8 papers (2016–2022)John D. Potter · University of Washington Applied Physics Laboratory7 papers (2014–2018)Loı̈c Le Marchand · The London College7 papers (2014–2023)Sonja I. Berndt · Department of Health and Human Services7 papers (2014–2021)Emily White · Cape Town HVTN Immunology Laboratory / Hutchinson Centre Research Institute of South Africa7 papers (2014–2021)Daniel D. Buchanan · Morehouse College6 papers (2019–2023)Graham G. Giles · Monash Institute of Medical Research6 papers (2016–2021)Michael O. Woods · Binus University5 papers (2016–2022)Stephen B. Gruber · City Of Hope National Medical Center5 papers (2014–2021)Steven Gallinger · Ontario Institute for Cancer Research5 papers (2018–2021)Lori C. Sakoda · Seattle University4 papers (2019–2021)